Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study

By D. Hastan, W. Fokkens, C. Bachert, R. Newson, J. Bislimovska, A. Bockelbrink, P. Bousquet, G. Brożek, A. Bruno, S. Dahlén and 16 more. Allergy. European Journal of Allergy and Clinical Immunology, 2011

1,022 citations recorded by the source corpus.

Subfields: Immunology and Allergy, Otorhinolaryngology, Sensory Systems

View Paper: https://www.semanticscholar.org/paper/296b84d2a030203adcb635d58f063c4d2ed71318

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Tomassen
2. C. Bachert
3. N. Gandhi
4. G. Vandeplas
5. B. Ferguson
6. L. Mannent
7. T. Van Zele
8. L. Cardell

Citations in the corpus

• Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. (2016, methodology): “Patients were excluded if they: (1) had previously participated in any clinical trial of dupilumab; (2) had received corticosteroids (oral or intranasal), monoclonal antibodies, immunosuppressive treatment, or anti–immunoglobulin E (anti-IgE) therapy during the 2 months preceding the screening; (3) ”
• Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. (2016, methodology): “In a hierarchical cluster analysis of variables (illustrated in figure 1C), these were optimally clustered in the 6 following clusters: (1) IgE, ECP, IL-5, albumin, SE-IgE (2) IL1, IL6, IL8, MPO, (3) IL17, TNF-α, (4) TGF-β1 (5) IL-22 and (6) IFN-γ.”